PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Outset Medical, Inc. (OM)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US6901451079

CUSIP

690145107

Sector

Healthcare

IPO Date

Sep 15, 2020

Highlights

Market Cap

$53.07M

EPS (TTM)

-$2.74

Total Revenue (TTM)

$114.73M

Gross Profit (TTM)

$35.53M

EBITDA (TTM)

-$114.49M

Year Range

$0.44 - $5.96

Target Price

$4.00

Short %

6.22%

Short Ratio

2.94

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
OM vs. SPY OM vs. SGMO
Popular comparisons:
OM vs. SPY OM vs. SGMO

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Outset Medical, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%JulyAugustSeptemberOctoberNovemberDecember
-71.57%
7.29%
OM (Outset Medical, Inc.)
Benchmark (^GSPC)

Returns By Period

Outset Medical, Inc. had a return of -81.15% year-to-date (YTD) and -83.36% in the last 12 months.


OM

YTD

-81.15%

1M

46.07%

6M

-71.98%

1Y

-83.36%

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

23.11%

1M

-0.36%

6M

7.02%

1Y

23.15%

5Y*

12.80%

10Y*

11.01%

Monthly Returns

The table below presents the monthly returns of OM, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-43.81%3.62%-29.52%13.96%47.43%3.22%-7.79%-85.07%27.74%-15.81%57.23%-81.15%
20238.91%-18.88%-19.33%-2.23%15.79%4.99%-5.90%-33.87%-20.06%-67.46%48.02%3.24%-79.05%
2022-19.31%18.23%3.25%-23.17%-37.50%-31.83%3.97%18.38%-12.90%-2.45%35.65%22.49%-43.98%
2021-8.81%-3.94%9.24%10.17%-19.44%3.54%-18.05%20.34%0.30%7.75%-11.02%-2.76%-18.91%
2020-17.60%-7.06%37.72%-11.19%-6.33%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of OM is 13, meaning it’s performing worse than 87% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of OM is 1313
Overall Rank
The Sharpe Ratio Rank of OM is 1515
Sharpe Ratio Rank
The Sortino Ratio Rank of OM is 1717
Sortino Ratio Rank
The Omega Ratio Rank of OM is 1616
Omega Ratio Rank
The Calmar Ratio Rank of OM is 44
Calmar Ratio Rank
The Martin Ratio Rank of OM is 1414
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Outset Medical, Inc. (OM) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for OM, currently valued at -0.64, compared to the broader market-4.00-2.000.002.00-0.641.90
The chart of Sortino ratio for OM, currently valued at -0.74, compared to the broader market-4.00-2.000.002.004.00-0.742.54
The chart of Omega ratio for OM, currently valued at 0.90, compared to the broader market0.501.001.502.000.901.35
The chart of Calmar ratio for OM, currently valued at -0.84, compared to the broader market0.002.004.006.00-0.842.81
The chart of Martin ratio for OM, currently valued at -1.29, compared to the broader market0.0010.0020.00-1.2912.39
OM
^GSPC

The current Outset Medical, Inc. Sharpe ratio is -0.64. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Outset Medical, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
-0.64
1.90
OM (Outset Medical, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Outset Medical, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-98.41%
-3.58%
OM (Outset Medical, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Outset Medical, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Outset Medical, Inc. was 99.30%, occurring on Sep 12, 2024. The portfolio has not yet recovered.

The current Outset Medical, Inc. drawdown is 98.41%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.3%Dec 1, 2020951Sep 12, 2024
-29.94%Sep 16, 202018Oct 9, 202027Nov 17, 202045
-7.32%Nov 18, 20201Nov 18, 20202Nov 20, 20203
-5.27%Nov 25, 20201Nov 25, 20201Nov 27, 20202

Volatility

Volatility Chart

The current Outset Medical, Inc. volatility is 34.76%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovemberDecember
34.76%
3.64%
OM (Outset Medical, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Outset Medical, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Outset Medical, Inc..


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab